BSN

Cellmass 2.0 Blue Raz

F
N+ Score48
ProteinServing: 9.7 Gram(s)Type: Other Combinations [A1325]

Cellmass 2.0 Blue Raz is categorized as an "Other Combinations" supplement, though its name may suggest muscle recovery support. This product contains a total of 5 ingredients, including 20mg of Calcium, which research suggests is underdosed for typical bone health support. The product's N+ Score is 46, earning it an F grade, indicating it falls into the below-average tier for ingredient adequacy and overall formulation. While label transparency is 100%, the formula completeness is low at 25%, and no ingredients are present at clinically studied doses. This product may be considered by individuals seeking a general combination supplement, but its low score suggests limited efficacy based on current scientific understanding of ingredient dosages.

About This Product

Cellmass 2.0 Blue Raz by BSN is a protein supplement containing 5 active ingredients. It has earned an N+ Score of 48/100 (Grade F).

N+ Score Breakdown

Ingredient Adequacy0/100

Are key ingredients present at clinically effective doses based on research?

Formula Completeness33/100

Does the product include all expected ingredients for its supplement category?

Label Transparency100/100

Are individual ingredient amounts clearly disclosed without proprietary blends?

Ingredient Diversity100/100

Does the formula include a breadth of beneficial compounds from multiple pathways?

Strengths

  • +Fully transparent label with individual ingredient amounts disclosed
  • +Broad ingredient diversity exceeding category norms

Weaknesses

  • Several ingredients below clinically effective doses
  • Missing several expected ingredients for its category

Ingredient Analysis (5 ingredients)

IngredientAmountDose Adequacy
Calories10.000 {Calories}N/A
Calcium20.000 mgUnder
Total Carbohydrates1.000 gN/A
Protein2.000 gN/A
Cellmass 2.0 Proprietary Blend8.300 gN/A

Clinical ranges based on NIH ODS Fact Sheets and peer-reviewed research. Status indicates whether the amount meets evidence-based thresholds.